三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

News

Understand the latest news of Leadingpharm

Congratulation! | Congratulate Mr. Tao Xinhua, Chairman of Leadingpharm, on Awarding the Title of "Top 10 Rising Star of China’s Pharmaceutical Industry in 2020"

Release time:2021-10-19

Recently, the "Most Influential Company Press Conference of China's Pharmaceutical Industry in 2020" hosted by the All-China Federation of Industry and Commerce Medical & Pharmaceutical Chamber was released in Jinan, Shandong Province. Mr. Tao Xinhua, chairman of Leadingpharm, won the honorary title of "Top 10 Rising Star of China’s Pharmaceutical Industry in 2020 - Leader of CXO-Whole-Industry-Chain Service System "!

The award speech mentioned that Mr. Tao Xinhua has always cherished the corporate vision of “We make China a world-class player in pharmaceutical technology development and production process!”, committed to promoting the development of China's pharmaceutical industry with innovative R & D and service modes and information technology, led the team to overcome the technical barriers of high-end preparations, and promoted the development of China's generic drug consistency evaluation to a higher level.

At the same time, with an open and shared attitude, he established Leadingpharm CXO Integrated Service Model covering the whole life cycle of pharmaceutical R & D including preclinical research, clinical CRO and CDMO, created a unique and more dynamic cooperation model in the industry, and effectively promoted the transformation and implementation of pharmaceutical innovation achievements.

Under the macro policy guidance of the government, which vigorously promote the innovation and development of biomedicine, China's pharmaceutical industry is experiencing the industrial upgrading of "comprehensive independent innovation". During this period, a number of advanced collectives and individuals who dare to be the first and bravely stand at the forefront have emerged, of which Mr. Tao Xinhua is one of the representatives.

The character of innovative medicine research is like a long and thorny track, which process is more like a relay race. Some people need to do basic research, some people do application transformation, and some people do market development. From drug discovery to drug into the market, multi-disciplinary close cooperation is needed. With the increasingly stringent national requirements for innovative medicine research, the risk of which is increasing, which means companies should fully examine their own strength, comprehensively consider their own culture, ability and other factors, and follow the trend. The real differentiated competition is the differentiation of company core competitiveness, rather than differentiation of research. Based on the profound accumulation of the Leadingpharm in the field of pharmaceutical R & D, Mr. Tao Xinhua took the lead in putting forward the concept of Leadingpharm CXO Closed-loop Service System of the whole industrial chain, and established an open service platform covering the whole life cycle including new drug screening, preclinical research, clinical research and CDMO service, which can provide one-stop services with higher adaptability for the incubation of innovative projects, and help scientists solve the "last mile" problem of the listing of innovative products, empower innovative industries and lead the industry to be  more intensive and develop with higher quality.

With the full implementation of marketing authorization holder (MAH) system, marketing authorization holder bear legal responsibility for drug safety, effectiveness and controllable quality. However, many MAH companies' talent and quality control systems are relatively weak, resulting in the smooth implementation of the project. To solve this problem, Mr. Tao Xinhua guided the service upgrading of Leadingpharm CXO System, helped innovative companies with a series of management outputs such as document system construction, QA management system construction, pharmaceutical registration and compliance construction, helped companies fill innovation loopholes and promoted the transformation and implementation of innovative achievements.

The CXO Service Industry has been selected and won awards for the first time since the establishment of “the Most Influential Company Press Conference of Pharmaceutical Industry”, which also means that CXO service plays an increasingly important role in the whole pharmaceutical field. CXO integration in the whole quadrant will become a general trend of industry development. The Pharmaceutical industry has begun to tilt from industrial and commercial leadership to CXO, which makes the leaders of CXO play an increasingly prominent role in the whole industry.

“We make China a world-class player in pharmaceutical technology development and production process!” is the common wish of every member in Leadingpharm. It is the responsibility of every pharmaceutical person to realize the strategy for the rejuvenation of Chinese medicine. Tao Xinhua, chairman of the board, has always cherished a strong sense of patriotism, taking the realization of our nation's pharmaceutical rejuvenation as his own responsibility, doing solid work, taking the lead, leading companies to constantly explore the road of innovation and development, and making positive contributions to the nation's pharmaceutical rejuvenation.

Finally, congratulate Mr. Tao Xinhua again on awarding the title of "Top 10 Rising Star of China’s Pharmaceutical Industry in 2020" ! Congratulations to Leadingpharm for being the top 50 pharmaceutical R & D companies in China, and won many honors such as Law-abiding and Honest Enterprise in China's Pharmaceutical Industry in 2020, Top 50 Growth Enterprises in China's Pharmaceutical Industry in 2020, Top 50 of Independent Innovation Private Enterprise! Thanks every medical person for working hard for national rejuvenation!




-END-

 

 

 

 

 

 

 

 

轉(zhuǎn)載聲明:未經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán),不得轉(zhuǎn)載、摘編或利用其他方式使用上述作品。已經(jīng)本網(wǎng)或本網(wǎng)權(quán)利人授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:新領(lǐng)先醫(yī)藥科技”。

Recommend

久久久亚洲熟妇熟女电影| 青苹果乐园影院在线播放| 欧洲码亚洲码的区别入口| 国产黑丝诱惑在线看91| 亚洲国产精品无码久久| 欧美日韩精品一区在线播放| 中文字幕第一页在线播放| 亚洲一区二区中文字幕av| 97精品日韩永久性无码| 日韩精品1000夫妇激情| 亚洲国产午夜福利精品大秀| 色噜噜偷拍精品综合在线| 亚洲欧洲精品无码久久久| 国产成人a视频在线观看| 天天爽夜夜爽人人爽| 亚洲 自拍 另类 欧美 综合| 日产亚洲一区二区三区| 狠狠噜天天噜日日噜无码| 久久久亚洲综合久久88| 日韩电影免费在线一区二区| 国产av无码亚洲avh| 一区二区三区四区一道本| 中文字幕乱码熟女一区二区| 国产成人精品一二三四区| 国产亚洲精品a在线看。| 国产午夜人做人免费视频| 精品无码国产一区二区三区.| 国产999一区二区三区| 亚洲人一区二区中文字幕| 丰满熟女一区二区三区三州| 欧美色精品人妻在线视频| 在线观看91精品国产性| 色悠悠国产精品免费观看| 加勒比五月综合久久伊人| 老司机在线精品视频播放| 97人妻精品全国免费视频| 无码少妇一区二区三区浪潮av | 果冻星空传媒mv在线观看| 亚洲自拍偷拍另类综合图区| 日本欧美精品一区二区三区| 亚洲之爱青娱乐|